Journals / Adıyaman Üniversitesi Sağlık Bilimleri Dergisi / 2022 / Cilt: 8 - Sayı: 3

The musculoprotective effects of thymoquinone on ameliorating soleus muscle damage induced by valproic acid in rats

Sıçanlarda valproik asidin neden olduğu soleus kas hasarını iyileştirmede timokinonun koruyucu etkileri

Pages
170–180
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

TQ may be beneficial in treating soleus muscle damage caused by VPA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: To determine the potential musculoprotective effects of thymoquinone (TQ) on valproic acid (VPA)-induced muscle damage.
📊
Key Findings & Data:Materials and Methods: Twenty-one male Spraque-Dawley rats were randomly separated into 3 groups (n = 7): Control, VPA, VPA + TQ.
💡
Conclusion & Impact:TQ may be beneficial in treating soleus muscle damage caused by VPA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Timokinon · Valproik asit · Apoptoz

Abstract

Aim: To determine the potential musculoprotective effects of thymoquinone (TQ) on valproic acid (VPA)-induced muscle damage. Materials and Methods: Twenty-one male Spraque-Dawley rats were randomly separated into 3 groups (n = 7): Control, VPA, VPA + TQ. Oral VPA (500 mg/kg/day) and TQ (50 mg/kg/day) were given to the rats for a period of 14 days. On the 15th day, soleus muscle tissues were taken for evaluating the expression levels of the Alpha-actinin-3 (ACTN3) and Myosin heavy chain 7 (MYH7) genes and histological analysis. Results: The VPA + TQ group showed significantly higher ACTN3 and lower MYH7 gene expression, and decreased NADPH oxidase-4 (NOX4) and caspase-3 (CAS-3) levels than the VPA group. Also, histopathological changes were decreased in the VPA + TQ group in comparison with the VPA group. Conclusion: VPA-induced soleus muscle damage was alleviated due to the antioxidant and antiapoptotic effects of TQ. TQ may be beneficial in treating soleus muscle damage caused by VPA.

Özet

Amaç: Çalışmada timokinonun (TQ) valproik asit (VPA) kaynaklı kas hasarı üzerindeki potansiyel koruyucu etkilerinin belirlenmesi amaçlanmıştır. Gereç ve Yöntem: Yirmi bir erkek Spraque-Dawley sıçan rastgele 3 gruba ayrıldı (n = 7): Kontrol, VPA, VPA + TQ. Sıçanlara 14 gün süreyle oral VPA (500 mg/kg/gün) ve TQ (50 mg/kg/gün) verildi. Onbeşinci günde, Alfa-aktinin-3 (ACTN3) ve Miyozin ağır zincir 7 (MYH7) genlerinin ekspresyon düzeylerinin belirlenmesi ve histolojik analiz için soleus kas dokuları alındı. Bulgular: VPA + TQ grubunda, VPA grubuna göre önemli ölçüde daha yüksek ACTN3 ve daha düşük MYH7 gen ekspresyonu ile düşük NADPH oksidaz-4 (NOX4) ve kaspaz-3 (CAS-3) seviyeleri gözlendi. Ayrıca VPA + TQ grubunda VPA grubuna göre histopatolojik değişikliklerin azaldığı da görüldü. Sonuç: TQ'un antioksidan ve antiapoptotik etkileri nedeniyle VPA kaynaklı soleus kas hasarını hafiflettiği ve kas hasarını tedavi etmede faydalı olabileceği sonucuna varılmıştır.

🔖

Cite This Article

AZİRAK, S., KORKMAZ, D. T., BİLGİÇ, S., SEVİMLİ, M., ÖZER, M. K. (2022). The musculoprotective effects of thymoquinone on ameliorating soleus muscle damage induced by valproic acid in rats. Adıyaman Üniversitesi Sağlık Bilimleri Dergisi, Cilt: 8 - Sayı: 3, 170–180. https://ajindex.com/articles/866732

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Romoli M, Mazzocchetti P, D'Alonzo R, et al. Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences. Curr Neuropharmacol. 2019;17(10):926-946.
  2. Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol(Phila). 2009;47(2):101-111.
  3. Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid. Clin Biochem. 2013;46(15):1323-1338.
  4. Cornago M, Garcia-Alberich C, Blasco-Angulo N, et al. Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe. Cell Death Dis. 2014; 5(10):e1435. Yiew KH, Chatterjee TK, Hui DY, Weintraub NL. Histone Deacetylases and Cardiometabolic Diseases. Arterioscler Thromb Vasc Biol. 2015;35(9):1914-1919.
  5. Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov. 2014;13(9):673-691.
  6. Moresi V, Marroncelli N, Pigna E, et al. Histone Deacetylase 4 is crucial for proper skeletal muscle development and disease. Italian Journal of Anatomy and Embryology. 2015;120(1):150. Alamdari N, Aversa Z, Castillero E, Hasselgren PO. Acetylation and deacetylation--novel factors in muscle wasting. Metabolism. 2013;62(1): 1-11.
  7. Turkyilmaz IB, Sokmen BB, Yanardag R. Alpha-lipoic acid prevents brain injury in rats administered with valproic acid. J Biochem Mol Toxicol. 2020;34(11):e22580. Tu C, Allen A, Deng W, et al. Commonly used thiol-containing antioxidants reduce cardiac differentiation and alter gene expression ratios of sarcomeric isoforms. Exp Cell Res. 2018;370(1):150-159.
  8. Wells PG, McCallum GP, Chen CS, et al. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci. 2009;108(1):4-18.
  9. Bimonte S, Albino V, Barbieri A, et al. Dissecting the roles of thymoquinone on the prevention and the treatment of hepatocellular carcinoma: an overview on the current state of knowledge. Infect Agent Cancer. 2019;14:10. Allen DL, Loh AS. Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol. 2011;300(1):C124-137. Stead CA, Hesketh SJ, Bennett S, et al. Fractional Synthesis Rates of Individual Proteins in Rat Soleus and Plantaris Muscles. Proteomes. 2020;8(2):10. Chakkalakal JV, Kuang S, Buffelli M, Lichtman JW, Sanes JR. Mouse transgenic lines that selectively label Type